Piper Sandler Reiterates Overweight Rating on Gilead Sciences (GILD)
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro reiterated an Overweight rating and $95.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
